Literature DB >> 15168135

Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway.

Kanako Chikai1, Akiko Ohnishi, Tsutomu Kato, Jun Ikeda, Yutaka Sawamura, Yoshinobu Iwasaki, Tomoo Itoh, Hirofumi Sawa, Kazuo Nagashima.   

Abstract

Five cases of pilomyxoid astrocytoma (PmA) characterized by a monophasic pattern with a myxoid background were selected for a clinicopathological study from 23 cases previously diagnosed as pilocytic astrocytoma (PA). All PmA patients were either infants or young children (mean age 2.1 years), and all tumors were located in the optic chiasm/hypothalamus region. All cases received chemotherapy, which reduced tumor size, and the location of the tumor became confined to the optic chiasm. In two cases, tumor recurrence occurred 3 and 7 years after chemotherapy. Histology of the recurrent tumors showed the biphasic pattern of classical PA. Hence, we conclude that PmA might be an infantile form of PA and speculate that a subset of PmA in the optic pathway/hypothalamus originates from the optic chiasm, possibly derived from radial glia existing in the embryonic optic chiasm.

Entities:  

Mesh:

Year:  2004        PMID: 15168135     DOI: 10.1007/s00401-004-0858-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas.

Authors:  Bálint Alkonyi; Johannes Nowak; Astrid K Gnekow; Torsten Pietsch; Monika Warmuth-Metz
Journal:  Neuroradiology       Date:  2015-02-10       Impact factor: 2.804

Review 2.  Pediatric sellar and suprasellar lesions.

Authors:  Jason W Schroeder; L Gilbert Vezina
Journal:  Pediatr Radiol       Date:  2011-01-26

3.  Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.

Authors:  Hamid Borghei-Razavi; Shunsuke Shibao; Uta Schick
Journal:  Neurosurg Rev       Date:  2016-05-26       Impact factor: 3.042

4.  Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA.

Authors:  Bette K Kleinschmidt-DeMasters; Andrew M Donson; Hannes Vogel; Nicholas K Foreman
Journal:  Brain Pathol       Date:  2015-01-27       Impact factor: 6.508

5.  The pilomyxoid astrocytoma and its relationship to pilocytic astrocytoma: report of a case and a critical review of the entity.

Authors:  Eugene P Ceppa; Eric Bouffet; Robert Griebel; Chris Robinson; Tarik Tihan
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

Review 6.  Optic pathway gliomas: a review.

Authors:  Iris Fried; Uri Tabori; Tarik Tihan; Arun Reginald; Eric Bouffet
Journal:  CNS Oncol       Date:  2013-03

7.  Role of surgery for optic pathway/hypothalamic astrocytomas in children.

Authors:  Yutaka Sawamura; Kyousuke Kamada; Yuuta Kamoshima; Shigeru Yamaguchi; Toshihiro Tajima; Junko Tsubaki; Takamitsu Fujimaki
Journal:  Neuro Oncol       Date:  2008-07-08       Impact factor: 12.300

8.  The role of early intra-operative MRI in partial resection of optic pathway/hypothalamic gliomas in children.

Authors:  Christopher Paul Millward; Sandra Perez Da Rosa; Shivaram Avula; Jonathan R Ellenbogen; Michaela Spiteri; Emma Lewis; Mo Didi; Conor Mallucci
Journal:  Childs Nerv Syst       Date:  2015-07-28       Impact factor: 1.475

9.  Surgical and clinical aspects of cerebellar pilomyxoid-spectrum astrocytomas in children.

Authors:  Mohamed A El Beltagy; Mostafa M E Atteya; Alaa El-Haddad; Madiha Awad; Hala Taha; Mohamed Kamal; Sherif Abou El Naga
Journal:  Childs Nerv Syst       Date:  2014-02-05       Impact factor: 1.475

Review 10.  Significance of radical resection for pilomyxoid astrocytoma of the cerebellum: a case report and review of the literature.

Authors:  Atsushi Okano; Soichi Oya; Naoaki Fujisawa; Tsukasa Tsuchiya; Masahiro Indo; Takumi Nakamura; Han Soo Chang; Toru Matsui
Journal:  Childs Nerv Syst       Date:  2013-03-17       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.